E. Puchelle (Reims, France), H. Inoue (Kyushu, Japan)
Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring
V. Sorbello, B. Pergolizzi, A. Sillo, S. Bozzaro, V. De Rose (Orbassano, Italy)
|  |
Transient over-expression of bioactive PDGF-BB induces lung fibrosis
J. C. Rodriguez-Lecompte, K. Ask, A. Froese, K. Linher, K. Martin, J. Gauldie (Hamilton, Canada)
| |
WFDC2 (HE4) and SLPI are differentially expressed in normal and diseased human lung and in lung cancer
C. D. Bingle, S. S. Cross, A. S. High, W. A. Wallace, D. Rassl, L. Bingle (Sheffield, Leeds, Edinburgh, Cambridge, United Kingdom)
|  |
Regulation of PMN apoptosis in the airways during community acquired pneumonia in COPD patients and controls
A. Strassburg, A. Luers, K. Dalhoff (Luebeck, Germany)
| |
Differential expressions of MUC1 mucin with various glycosylation during lung development
J. Sakurai, N. Hattori, A. Yokoyama, N. Kohno (Hiroshima, Japan)
| |
The human endogenous antibiotic LL-37 promotes growth of lung cancer cells
J. von Haussen, R. Shaykhiev, R. Koczulla, A. Aigner, F. Czubayko, R. Bals (Marburg, Germany)
| |
Detection of extracellular proteasome in the human alveolar space
S. U. Sixt, M. Adamzik, J. Hakenbeck, D. Spyrka, B. Saul, M. Beiderlinden, H. P. Jennissen, J. Peters (Essen, Germany)
| |